SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
H&Q LIFE SCIENCES INVESTORS
------------------------------------------
(Name of Issuer)
Common Stock, par value $0.01 per share
------------------------------------------
(Title of Class of Securities)
404052-10-0
------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
- -------------------------------------------------------------------------
1. Name and I.R.S. Identification No. of Reporting Person:
Yale University
I.R.S. Number 06-0646973-N
- -------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group:
(a) (Not Applicable)
(b) (Not Applicable)
- -------------------------------------------------------------------------
3. SEC Use Only
- -------------------------------------------------------------------------
4. Citizenship or Place of Organization:
Yale University is a Connecticut corporation.
- -------------------------------------------------------------------------
Number of Shares 5. Sole Voting Power - 480,700
Beneficially Owned by ------------------------------------------------
Each Reporting 6. Shared Voting Power (Not Applicable)
Person With: ------------------------------------------------
7. Sole Dispositive Power - 480,700
------------------------------------------------
8. Shared Dispositive Power (Not Applicable)
- -------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
480,700
- -------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(Not Applicable)
- -------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9): 7.2%
- -------------------------------------------------------------------------
12. Type of Reporting Person: EP
- -------------------------------------------------------------------------
Page 1 of 3
<PAGE>
Item 1. Issuer:
(a) Name of Issuer:
H&Q Life Sciences Investors (the "Company")
(b) Address of Issuer's Principal Executive Office:
H&Q Capital Management Incorporated
50 Rowes Wharf - 4th Floor
Boston, MA 02110-3328
Item 2. Person Filing:
(a) Name of Person Filing:
Yale University
(b) Address of Principal Office:
Yale University
Investments Office
230 Prospect Street
New Haven, CT 06511-2107
(c) Citizenship:
Yale University is a Connecticut corporation.
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
404052-10-0
Item 3. Status of Person Filing:
If this statement is filed pursuant to rules 13d-1(b) or 13d-2(b), check
whether the person filing is a:
....
(f) [X]...Endowment Fund; see section 13d-1(b)(1)(ii)(F).
....
Item 4. Ownership:
(a) Amount Beneficially Owned: 480,700
(b) Percent of Class: 7.2%
Page 2 of 3
<PAGE>
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote:
480,700
(ii) shared power to vote or to direct the vote:
(Not Applicable)
(iii) sole power to dispose or to direct the disposition of:
480,000
(iv) shared power to dispose or to direct the disposition of:
(Not Applicable)
Item 5. Ownership of Five Percent or Less of a Class:
(Not Applicable)
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
(Not Applicable)
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company:
(Not Applicable)
Item 8. Identification and Classification of Members of Group:
(Not Applicable)
Item 9. Notice of Dissolution of Group:
(Not Applicable)
Item 10. Certification:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose of
and do not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in connection
with or as a participant in any transaction having such purpose or
effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
/s/ David F. Swensen
Date: February 6, 1997 --------------------------------
Signature
Name: David F. Swensen
Title: Chief Investment Officer
Page 3 of 3
